Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Exceptional Response to Nanoparticle Albumin-Bound Paclitaxel and Gemcitabine in a Patient with a Refractory Adenocarcinoma of the Ampulla of Vater.

Kapp M, Kosmala A, Kircher S, Luber V, Kunzmann V.

Case Rep Oncol. 2016 Jan 8;9(1):15-24. doi: 10.1159/000443304. eCollection 2016 Jan-Apr.

2.

Programmed death 1 blockade, an Achilles heel for MMR-deficient tumors?

Lin AY, Lin E.

J Hematol Oncol. 2015 Nov 5;8:124. doi: 10.1186/s13045-015-0222-5.

3.

Metabolic Characteristics of Advanced Biliary Tract Cancer Using 18F-Fluorodeoxyglucose Positron Emission Tomography and Their Clinical Implications.

Cho KM, Oh DY, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Bang YJ.

Oncologist. 2015 Aug;20(8):926-33. doi: 10.1634/theoncologist.2014-0356. Epub 2015 Jun 22.

4.

Imaging of malignancies of the biliary tract- an update.

Hennedige TP, Neo WT, Venkatesh SK.

Cancer Imaging. 2014 Apr 22;14:14. doi: 10.1186/1470-7330-14-14. Review.

5.

Association of metabolic syndromes and risk factors with ampullary tumors development: a case-control study in China.

He XD, Wu Q, Liu W, Hong T, Li JJ, Miao RY, Zhao HT.

World J Gastroenterol. 2014 Jul 28;20(28):9541-8. doi: 10.3748/wjg.v20.i28.9541.

6.

Gene expression profiling of ampullary carcinomas classifies ampullary carcinomas into biliary-like and intestinal-like subtypes that are prognostic of outcome.

Overman MJ, Zhang J, Kopetz S, Davies M, Jiang ZQ, Stemke-Hale K, Rümmele P, Pilarsky C, Grützmann R, Hamilton S, Hwang R, Abbruzzese JL, Varadhachary G, Broom B, Wang H.

PLoS One. 2013 Jun 11;8(6):e65144. doi: 10.1371/journal.pone.0065144. Print 2013. Erratum in: PLoS One. 2013;8(7). doi:10.1371/annotation/6afdd046-e1a7-4421-b7ec-0c9492ce2544. Zhi-Qin, Jiang [corrected to Jiang, Zhi-Qin].

7.

A retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapy.

Jiang ZQ, Varadhachary G, Wang X, Kopetz S, Lee JE, Wang H, Shroff R, Katz M, Wolff RA, Fleming J, Overman MJ.

Ann Oncol. 2013 Sep;24(9):2349-53. doi: 10.1093/annonc/mdt191. Epub 2013 May 22.

8.

2564 resected periampullary adenocarcinomas at a single institution: trends over three decades.

He J, Ahuja N, Makary MA, Cameron JL, Eckhauser FE, Choti MA, Hruban RH, Pawlik TM, Wolfgang CL.

HPB (Oxford). 2014 Jan;16(1):83-90. doi: 10.1111/hpb.12078. Epub 2013 Mar 8.

9.

Review of the investigation and surgical management of resectable ampullary adenocarcinoma.

Askew J, Connor S.

HPB (Oxford). 2013 Nov;15(11):829-38. doi: 10.1111/hpb.12038. Epub 2013 Jan 10. Review.

10.

Irrelevance of microsatellite instability in the epidemiology of sporadic pancreatic ductal adenocarcinoma.

Laghi L, Beghelli S, Spinelli A, Bianchi P, Basso G, Di Caro G, Brecht A, Celesti G, Turri G, Bersani S, Schumacher G, Röcken C, Gräntzdörffer I, Roncalli M, Zerbi A, Neuhaus P, Bassi C, Montorsi M, Scarpa A, Malesci A.

PLoS One. 2012;7(9):e46002. doi: 10.1371/journal.pone.0046002. Epub 2012 Sep 21.

11.

Tumors of ampulla of Vater: A case series and review of chemotherapy options.

Romiti A, Barucca V, Zullo A, Sarcina I, Di Rocco R, D'Antonio C, Latorre M, Marchetti P.

World J Gastrointest Oncol. 2012 Mar 15;4(3):60-7. doi: 10.4251/wjgo.v4.i3.60.

12.

Application of the U.S. EPA mode of action Framework for purposes of guiding future research: a case study involving the oral carcinogenicity of hexavalent chromium.

Thompson CM, Haws LC, Harris MA, Gatto NM, Proctor DM.

Toxicol Sci. 2011 Jan;119(1):20-40. doi: 10.1093/toxsci/kfq320. Epub 2010 Oct 14. Review.

13.

Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas.

Ohike N, Coban I, Kim GE, Basturk O, Tajiri T, Krasinskas A, Bandyopadhyay S, Morohoshi T, Shimada Y, Kooby DA, Staley CA, Goodman M, Adsay NV.

Am J Surg Pathol. 2010 Oct;34(10):1417-24. doi: 10.1097/PAS.0b013e3181f0b05a. Erratum in: Am J Surg Pathol. 2010 Dec;34(12):1892. Volkan Adsay, Nazmi [corrected to Adsay, N. Volkan].

Items per page

Supplemental Content

Write to the Help Desk